Francis (Frank) Reynolds is President and CEO of InVivo Therapeutics, and is leading InVivo’s teams to commercialize novel neurological technologies that were developed at Massecheusetts Institute of Technology and Harvard Medical School. InVivo is located in Cambridge, Massacheusetts and employs 10. Prior to founding InVivo Therapeutics in 2005, Reynolds was Director, Global Business Development for Siemens Corporations where he was responsible for new business revenue in 132 countries. He was also founder and CEO of Expand The Knowledge, Inc. A graduate of the Sloan Fellows Progam at MIT, where he completed his MBA and coursework at Harvard Business School, Reynolds is also a graduate of the Wharton School of Business, The University of Pennsylvania and Saint Joseph University. His career plans are focused on expanding InVivo Therapeutics Corporation and bringing the first successful treatment option for traumatic spinal cord injury to market. Reynolds was born in NYC to Irish parents – his mother from Mayo and father from Leitrim. He resides in Pennsylvania.
Return to Life Science 50